You Position: Home > Paper

Research progress of new antimicrobial agents for drug-resistant pathogenic bacteria

( views:0, downloads:0 )
Author:
No author available
Journal Title:
Chinese Journal of Clinical Infectious Diseases
Issue:
4
DOI:
10.3760/cma.j.issn.1674-2397.2021.04.002
Key Word:
抗菌药物;细菌耐药;β-内酰胺酶;噁唑烷酮类抗菌药物;糖肽类抗生素;喹诺酮类抗菌药物;抗真菌药物;Anti-bacterial agents;Bacterial resistance;β-lactamase;Oxazolidinones;Glycopeptide antibiotics;Quinolone antibacterial drugs;Antifungal drugs

Abstract´╝Ü This article reviews the status quo of new antimicrobial agents that have been approved or undergoing phase Ⅱ/Ⅲ clinical trials in last five years at home and abroad, including new β-lactamase inhibitors and their compound preparations, oxazolidinones, tetracyclines, aminoglycosides, glycopeptides, quinolones, new antifungal agents, cyclic lipopeptides and new anti-mycobacterial agents. The antibacterial activities, main mechanisms of drug resistance, and progress of clinical studies of 27 new drugs were introduced to provide a reference for their clinical application.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn